Better Buy Under $5: Bombardier (TSX:BBD.B) or Green Organic Dutchman (TSX:TGOD)?

Some cheap stocks are worth the trouble. Find out whether Bombardier, Inc (TSX:BBD.B) and The Green Organic Dutchman Holdings Ltd (TSX:TGOD) are good, cheap options right now.

| More on:
data analytics, chart and graph icons with female hands typing on laptop in background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Many investors turn to very cheap stocks in the hope that their prices will skyrocket, allowing them to benefit from significant capital appreciation. Of course, some stocks are cheap for a reason, and finding a diamond in the rough can be a challenge. Let’s turn our attention to two stocks that are currently under $5: Bombardier (TSX:BBD.B) and the Green Organic Dutchman Holdings (TSX:TGOD). Which of these two has more upside?

Bombardier’s fall from grace

Bombardier was in far better shape at the turn of the millennium. However, the company’s share price has declined since then, and for the better part of 15 years, Bombardier’s stock has been around the $5 mark. The aerospace company’s stock is currently priced just above $2 (at writing), but while some investors might see an opportunity, I am still firmly in the camp of the naysayers.

To be fair, Bombardier made decent strides recently. Airbus acquired a majority stake in Bombardier’s CSeries Aircraft Limited Partnership. While the CSeries jet always had a lot going its way — most notably fuel efficiency given its size — things were going increasingly awry with Bombardier at the helm. Handing over control to Airbus, a company better capable of maximizing profits and minimizing costs, was supposed to increase efficiency and profitability.

The news of a partnership with Airbus (which came in 2017) sent Bombardier’s stock surging by up to about 150% in the following months. However, the company’s stock price has since stopped defying gravity. Though Bombardier boasts considerable backlog order of nearly $34 billion, its overall debt level is still a bit uncomfortable. The stock has spent too much time scraping the bottom of the barrel.

Can Green Organic Dutchman succeed in the cannabis market?

TGOD is a cannabis stock, and unlike Bombardier, it hasn’t been around for very long (about seven years). The cannabis market is still very young, and TGOD is one of those companies actively trying to cash in from the mesmerizing growth in sales the sector will experience over the next few years. TGOD focuses on growing pot organically and is also looking to profit the high-margin cannabis-infused beverage market.

TGOD’s production capacity is currently estimated to reach peak levels of about 220,000 kilograms per year by the end of 2020, which isn’t bad at all compared to most of its peers. In fact, this figure would very comfortably land TGOD in the top 10 Canadian cannabis companies in terms of production capacity.

Focusing on high-margin cannabis products — such as organically grown products or beverage-infused cannabis — is an excellent strategy given the danger of oversupply which plagues the dried cannabis market. Further, TGOD has a supply agreement with Ontario, Canada’s largest province, as well as with the largest wine distributor in Canada. TGOD also has footprints aboard, particularly in Poland via its subsidiary HemPoland.

Which should you buy?

Though TGOD probably isn’t the most exciting pot stock around — and the company’s top and bottom lines have been less than impressive — it currently looks to be a better buy than Bombardier. TGOD’s focus on high-margin products could help differentiate it from its peers at the point of sale, thus helping TGOD earn higher net margins overall. Bombardier has been trying to fully get back on its feet for too long, and the company has consistently failed, or at least its share price shows little sign of significant upward movement any time soon.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »